- Investing Ideas
- /
- Telecom Healthcare Sector
Telecom Healthcare Sector
Results
2304
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2304 companies
Sentient Brands Holdings
Market Cap: US$6.0m
A product development and brand management company, builds brands in the luxury and premium market space.
SNBH
US$0.051
7D
-7.3%
1Y
-12.1%
Cann Group
Market Cap: AU$9.3m
Engages in the breeding, cultivating, manufacturing, and selling medicinal cannabis in Australia and Europe.
CAN
AU$0.015
7D
-6.3%
1Y
n/a
SunLink Health Systems
Market Cap: US$6.0m
Through its subsidiaries, provides healthcare products and services in the southeastern United States.
SSY
US$0.86
7D
0%
1Y
43.4%
GENinCode
Market Cap: UK£4.4m
Develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient’s health based on their genes in the United Kingdom and internationally.
GENI
UK£0.015
7D
-3.1%
1Y
-81.2%
Chimeric Therapeutics
Market Cap: AU$9.3m
A clinical stage cell therapy company, develops and commercializes a range of cell therapies for oncology in Australia.
CHM
AU$0.004
7D
-50.0%
1Y
-82.6%
AppYea
Market Cap: US$5.9m
A digital health company, develops wearable monitoring solutions to treat sleep apnea and snoring.
APYP
US$0.0099
7D
-10.8%
1Y
-60.2%
Unified Global
Market Cap: US$5.9m
Operates as a vertically integrated cannabis company in Canada and the United States.
CHYL
US$0.10
7D
0%
1Y
n/a
Plus Therapeutics
Market Cap: US$5.8m
A clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer.
PSTV
US$0.31
7D
-38.2%
1Y
-85.5%
Biofrontera
Market Cap: US$5.7m
A biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.
BFRI
US$0.67
7D
-4.6%
1Y
-37.0%
HealthLynked
Market Cap: US$5.7m
A healthcare technology company, operates a cloud-based patient information network and record archiving system in the United States.
HLYK
US$0.02
7D
-17.1%
1Y
-60.3%
Intensity Therapeutics
Market Cap: US$5.7m
A late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States.
INTS
US$0.36
7D
-27.8%
1Y
-92.9%
Sigyn Therapeutics
Market Cap: US$5.7m
A development-stage company, provides therapeutic solutions to treat cancer and infectious disease disorders in the United States.
SIGY
US$3.53
7D
0%
1Y
-32.8%
Mobile-health Network Solutions
Market Cap: US$5.6m
An investment holding company, provides telehealth solutions primarily in Singapore.
MNDR
US$1.34
7D
2.3%
1Y
-90.8%
Pasithea Therapeutics
Market Cap: US$5.6m
A clinical-stage biotechnology company, focuses on the discovery, research, and development of treatments for central nervous system (CNS) disorders, RASopathies, and cancers.
KTTA
US$0.94
7D
9.3%
1Y
-85.6%
HeraMED
Market Cap: AU$8.8m
A medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States.
HMD
AU$0.011
7D
-42.1%
1Y
-31.3%
Rakovina Therapeutics
Market Cap: CA$7.7m
A biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets.
RKV
CA$0.06
7D
20.0%
1Y
-29.4%
Sproutly Canada
Market Cap: CA$7.6m
Produces and supplies water-soluble cannabis solutions and bio-natural oils to beverage and consumables markets in Canada.
SPR
n/a
7D
n/a
1Y
n/a
AEON Biopharma
Market Cap: US$5.5m
A clinical stage biopharmaceutical company, focuses on developing botulinum toxins.
AEON
US$0.55
7D
11.3%
1Y
-99.5%
180 Life Sciences
Market Cap: US$5.4m
A clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases in the United States.
ATNF
US$1.03
7D
-11.6%
1Y
-37.7%
BioCorRx
Market Cap: US$5.4m
Through its subsidiaries, develops and provides treatment programs for substance abuse and related disorders in the United States.
BICX
US$0.32
7D
2.9%
1Y
-59.0%
HITIQ
Market Cap: AU$8.4m
Engages in development and commercialization of concussion management technology and software in Australia.
HIQ
AU$0.02
7D
0%
1Y
0%
StateHouse Holdings
Market Cap: CA$7.7m
An integrated omni-channel cannabis company, engages in the cultivation, processing, manufacture, distribution, and retailing of cannabis products for the adult-use and medical markets in the United States.
STHZ
CA$0.03
7D
0%
1Y
-45.5%
FutureNet
Market Cap: US$5.4m
This record represents the public shell of FutureNet Inc.
FUUN
US$0.011
7D
0%
1Y
-56.4%
NutraProducts
Market Cap: US$5.3m
A contract manufacturer, engages in the production of gummy supplements.
NTPR
US$0.30
7D
164.1%
1Y
213.6%
N4 Pharma
Market Cap: UK£4.0m
A specialist pharmaceutical company, develops silica nanoparticle delivery systems to enhance the cellular delivery of cancer treatments, gene therapy, and vaccines in the United Kingdom.
N4P
UK£0.0047
7D
0%
1Y
-24.0%
CompuMed
Market Cap: US$5.3m
An enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities.
CMPD
US$3.49
7D
16.3%
1Y
99.4%
Sonoma Pharmaceuticals
Market Cap: US$5.3m
Develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye and nasal care, oral care, and dermatological conditions in the United States, Europe, Asia, Latin America, and internationally.
SNOA
US$3.32
7D
4.4%
1Y
-12.2%
bioAffinity Technologies
Market Cap: US$5.2m
Engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States.
BIAF
US$0.28
7D
33.9%
1Y
-88.8%
Sunshine Biopharma
Market Cap: US$5.2m
Operates as a pharmaceutical company that focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada.
SBFM
US$1.40
7D
6.1%
1Y
-90.6%
Check-Cap
Market Cap: US$5.2m
A clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel.
CHEK
US$0.85
7D
-6.1%
1Y
-62.5%
Clearmind Medicine
Market Cap: US$5.1m
A clinical pharmaceutical company, develops novel psychedelic medicines to treat under-served health problems.
CMND
US$1.00
7D
3.1%
1Y
-11.1%
Klotho Neurosciences
Market Cap: US$5.1m
Develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders.
KLTO
US$0.19
7D
-4.1%
1Y
-96.4%
ARCpoint
Market Cap: CA$7.1m
Provides franchise systems offering drug, alcohol, DNA, and clinical lab testing and screening services in the United States.
ARC
CA$0.065
7D
44.4%
1Y
-27.8%
Argent BioPharma
Market Cap: AU$7.9m
A multidisciplinary drug development Company, engages in the provision of medicines targeting immunology and neurology worldwide.
RGT
AU$0.12
7D
-4.2%
1Y
-70.9%
Kovo+ Holdings
Market Cap: CA$7.1m
Operates as a healthcare technology company.
KOVO
CA$0.04
7D
-11.1%
1Y
60.0%
IM Cannabis
Market Cap: CA$7.0m
Engages in breeding, growing, and supply of medical cannabis products in Israel and Germany.
IMCC
CA$2.27
7D
0%
1Y
-51.5%